Johan Lassus

ORCID: 0000-0003-4033-3232
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Cardiovascular Function and Risk Factors
  • Cardiac Structural Anomalies and Repair
  • Acute Myocardial Infarction Research
  • Cardiac pacing and defibrillation studies
  • Dialysis and Renal Disease Management
  • Acute Kidney Injury Research
  • Hemodynamic Monitoring and Therapy
  • Cardiac electrophysiology and arrhythmias
  • Potassium and Related Disorders
  • Sepsis Diagnosis and Treatment
  • Cardiac Fibrosis and Remodeling
  • Diabetes Treatment and Management
  • Chronic Kidney Disease and Diabetes
  • Electrolyte and hormonal disorders
  • Blood Pressure and Hypertension Studies
  • Ultrasound in Clinical Applications
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Cardiac Imaging and Diagnostics
  • Renal function and acid-base balance
  • Cardiac Ischemia and Reperfusion
  • GDF15 and Related Biomarkers
  • Cardiovascular Health and Disease Prevention

Helsinki University Hospital
2016-2025

University of Helsinki
2012-2025

Hôpital Louis Pradel
2019

Hospices Civils de Lyon
2019

Lung Institute
2017-2018

Turku University Hospital
2017

Satakunta Central Hospital
2017

Inserm
2012-2016

Universitat Autònoma de Barcelona
2016

Hospital de Sant Pau
2016

The objective of the EuroHeart Failure Survey II (EHFS II) was to assess patient characteristics, aetiology, treatment, and outcome acute heart failure (AHF) in Europe relation guidelines on diagnosis treatment AHF published by European Society Cardiology.Patients hospitalized for were recruited 133 centres 30 countries. Three thousand five hundred eighty patients entered into database end August 2005. Mean age 70 years, 61% male. New-onset (de novo AHF) diagnosed 37%, which 42% due coronary...

10.1093/eurheartj/ehl193 article EN European Heart Journal 2006-04-11
Theresa A. McDonagh Marco Metra Marianna Adamo Roy S. Gardner Andreas Baumbach and 95 more Michael Böhm Haran Burri Javed Butler Jelena Čelutkienė Ovidiu Chioncel John G.F. Cleland María G. Crespo‐Leiro Dimitrios Farmakis Martine Gilard Stéphane Heymans Arno W. Hoes Tiny Jaarsma Ewa A. Jankowska Mitja Lainščak Carolyn S.P. Lam Alexander R. Lyon John J.V. McMurray Alexandre Mebazaa Richard Mindham Claudio Muneretto Massimo Piepoli Susanna Price Giuseppe Rosano Frank Ruschitzka Anne Kathrine Skibelund Rudolf A. de Boer P. Christian Schulze Elena Arbelo Jozef Bartúnek Johann Bauersachs Michael A. Borger Sergio Buccheri Elisabetta Cerbai Erwan Donal Frank Edelmann Gloria Färber Bettina Heidecker Borja Ibáñez Stefan James Lars Køber Konstantinos C. Koskinas Josep Masip John W. McEvoy Robert J. Mentz Borislava Mihaylova Jacob Eifer Møller Wilfried Müllens Lis Neubeck Jens Cosedis Nielsen Agnès Pasquet Piotr Ponikowski Eva Prescott Amina Rakisheva Bianca Rocca Xavier Rosselló Leyla Elif Sade Hannah Schaubroeck Elena Tessitore Mariya Tokmakova Peter van der Meer Isabelle C. Van Gelder Mattias Van Heetvelde Christiaan Vrints Matthias Wilhelm Adam Witkowski Katja Zeppenfeld Naltin Shuka Mohammed Chettibi Hamlet Hayrapetyan Noémi Pávó Aysel İslamlı Anne‐Catherine Pouleur Zumreta Kušljugić Mariya Tokmakova Davor Miličić Theodoros Christodoulides Filip Málek Lars Køber M. Koriem Pentti Põder Johan Lassus François Roubille Vaja Agladze Stefan Frantz Alexia Stavrati Annamária Kosztin Inga Jóna Ingimarsdóttir Patricia Campbell Tal Hasin Fabrizio Oliva Nazipa Aidargaliyeva Gani Bajraktari Erkin М Мirrakhimov Ginta Kamzola Ali M El Neihoum

Poland), and Katja Zeppenfeld (

10.1093/eurheartj/ehad195 article EN European Heart Journal 2023-08-25

Whether acetazolamide, a carbonic anhydrase inhibitor that reduces proximal tubular sodium reabsorption, can improve the efficiency of loop diuretics, potentially leading to more and faster decongestion in patients with acute decompensated heart failure volume overload, is unclear.

10.1056/nejmoa2203094 article EN New England Journal of Medicine 2022-08-27

Vasopressors and inotropes remain a cornerstone in stabilization of the severely impaired hemodynamics cardiac output cardiogenic shock (CS). The aim this study was to analyze current real-life use these medications, their impact on outcome changes renal biomarkers over time CS.The multinational CardShock prospectively enrolled 219 patients with CS. vasopressors analyzed relation primary outcome, i.e., 90-day mortality, propensity score methods 216 follow-up data available. Changes until 96...

10.1186/s13054-016-1387-1 article EN cc-by Critical Care 2016-07-01

Acute heart failure (AHF) is associated with poor prognosis and requires recurrent hospitalizations. However, studies on AHF characteristics, treatment, prognostic factors are few. Our aim was to investigate the 1-year of identify in different clinical groups.We conducted a prospective multicentre study 620 patients hospitalized due AHF; mean age 75.1 (10.4) years, 50% male. Half had new-onset failure. congestion (63.5%) pulmonary oedema (26.3%) were most common presentations. Left...

10.1093/eurheartj/ehl407 article EN European Heart Journal 2006-04-07

Cystatin C, a novel marker of renal function, has been implicated as prognostic in cardiovascular disease. We investigated the value cystatin C acute heart failure (AHF) comparison to other markers function and NT-proBNP. Patients with measurements (n = 480) from prospective multicentre study on AHF were included. All-cause mortality at 12 months was 25.4%. creatinine, age, gender, systolic blood pressure admission identified independent risk factors. above median (1.30 mg/L) associated...

10.1093/eurheartj/ehl507 article EN European Heart Journal 2007-02-08

Increases in plasma B-type natriuretic peptide (BNP) concentrations those with acutely decompensated heart failure (ADHF) has been mainly attributed to an increase NPPB gene transcription. Recently, proBNP glycosylation emerged as a potential regulatory mechanism the production of amino-terminal (NT)-proBNP and BNP. The aim present study was investigate glycosylation, corin furin activities ADHF patients.Plasma levels proBNP, NT-proBNP, BNP, well concentration activity were measured large...

10.1093/eurheartj/ehu314 article EN European Heart Journal 2014-08-25
Coming Soon ...